Laddar...
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
Histone deacetylases (HDACs) enzymes, which affect the acetylation status of histones and other important cellular proteins, have been recognized as potentially useful therapeutic targets for a broad range of human disorders. Emerging studies have demonstrated that different types of HDAC inhibitors...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI AG
2014-05-01
|
| Serie: | Pharmaceuticals |
| Ämnen: | |
| Länkar: | http://www.mdpi.com/1424-8247/7/6/634 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|